Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Scynexis Achieves Merck Milestone | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Scynexis Achieves Merck Milestone

Scynexis, Inc. has received a payment from Merck for achieving a preclinical milestone in the companies’ oncology drug discovery and development collaboration.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Scynexis, Inc. has received a payment from Merck for achieving a preclinical milestone in the companies’ oncology drug discovery and development collaboration.

“We are pleased to celebrate success in reaching another milestone with our valued partner, Merck,” said Yves Ribeill, Ph.D., president and chief executive officer of Scynexis. “This milestone provides further validation of our long-term relationship with Merck in a number of therapeutic areas through discovery research and innovation.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics